We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$415M
AUM Growth
+$17.2M
(+4.3%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-3.8%
Top 10 Holdings %
Top 10 Hldgs %
43.54%
Holding
60
New
2
Increased
7
Reduced
37
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Henry Schein
HSIC
|
+$5.39M |
| 2 |
Broadcom
AVGO
|
+$4.99M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.24M |
| 4 |
UnitedHealth
UNH
|
+$1.9M |
| 5 |
Truist Financial
TFC
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$5.83M |
| 2 |
Zebra Technologies
ZBRA
|
+$3.75M |
| 3 |
Ulta Beauty
ULTA
|
+$3.48M |
| 4 |
Keysight
KEYS
|
+$3.06M |
| 5 |
PepsiCo
PEP
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.17% |
| 2 | Healthcare | 18.58% |
| 3 | Financials | 15.29% |
| 4 | Consumer Staples | 12.54% |
| 5 | Consumer Discretionary | 10.39% |
Similar funds
HCM
GS
IA
PAMS
SSWG
JWM
GDS
GPP
Foyston, Gordon, & Payne's Q1 2024 Portfolio in Review
As of Q1 2024, Foyston, Gordon, & Payne held 60 positions worth $415M, up 4.3% from $398M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $15.8M in Q1 2024, closing 2 positions and reducing 37 holdings. Its most notable exit was Humana, an estimated $5.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Eagle Materials worth $254K.
- Foyston, Gordon, & Payne's largest Q1 2024 buy was Eagle Materials: 933 shares worth $254K.
- Foyston, Gordon, & Payne added most to Henry Schein in Q1 2024, an estimated $5.39M increase.
- Foyston, Gordon, & Payne's biggest Q1 2024 reduction was Zebra Technologies, cutting an estimated $3.75M.
- Foyston, Gordon, & Payne fully exited Humana in Q1 2024, selling an estimated $5.83M.
- Foyston, Gordon, & Payne's ten largest holdings make up 44% of its $415M portfolio in Q1 2024.
- Foyston, Gordon, & Payne opened 2 new positions and closed 2 in Q1 2024.
- Foyston, Gordon, & Payne's portfolio value rose 4.3% quarter-over-quarter to $415M.
Based on Foyston, Gordon, & Payne's 13F filing for Q1 2024, filed 7 May 2024.